Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)
Clinical trial NCT03658967 · COMPLETED
Trial details
- NCT number
- NCT03658967
- Sponsor
- Herantis Pharma Plc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-07
- Primary completion
- 2019-12-16
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.